Report #2856218

Overview

Sex

Female

Age

4 yrs

State

CA

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (1)

Symptom narrative

wrong route; This non-serious case was reported by a nurse via call center representative and described the occurrence of intramuscular formulation administered by other route in a 4-year-old female patient who received DTPa-IPV (Kinrix) (batch number 5C79N, expiry date 19-OCT-2026) for prophylaxis. On an unknown date, the patient received Kinrix (subcutaneous). On an unknown date, an unknown time after receiving Kinrix, the patient experienced intramuscular formulation administered by other route (Verbatim: wrong route). The outcome of the intramuscular formulation administered by other route was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 22-AUG-2025 Nurse reported a 4-year-old patient received Kinrix subcutaneously instead of intramuscularly, which led to intramuscular formulation administered by other route. The reporter consented to follow up.